Altogether, these results converge to split our intracranial tumours in two distinct entities, one clustering with extracranial Smarcb1-deficient tumours, and the other clustering close to tumours of neuronal origin, that is, medulloblastomas and neuroblastomas. Here, SMARCB1 is linked to neoplasm.